EU-wide tender
Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V for the active substance Cinacalcet (excl. in standard pack size N3), ATC H05BX01, for the period 01.11.26-31.10.28 (incl. extension option 1x12 months)
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cinacalcet (ausschl. in der Normgröße N3), ATC H05BX01 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)
“Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V for the active substance Cinacalcet (excl. in standard pack size N3), ATC H05BX01, for the period 01.11.26-31.10.28 (incl. extension option 1x12 months)” is a eu-wide public tender. Offers are due by Wednesday, 5 September 2029, in 1039 days. Procedure: Open procedure, published EU-wide (above the EU thresholds).
- Deadline
- 5 September 2029, 1039 days left, 12:00
- Published
- 17 September 2026
- Procedure
- Open procedure
- Notice
- EU-wide (TED)
- Type of contract
- Supplies
- Estimated value
- not published
- Place of performance
- not stated
- Source, last checked
- TED, 1 November 2026
Contracting authority and documents
Contracting authority only with access
Original notice (German)Tender documents on the procurement platformIn short
A discount agreement for the active substance Cinacalcet is being procured for DAK-Gesundheit.
- The discount agreement applies to medicinal products containing the active substance Cinacalcet in standard pack size N3.
- Contracts start in November 2026 and end in October 2028.
- An extension option for twelve months is possible.
- All pharmaceutical companies can join at any time under the same conditions.
- Offers must be submitted via email, not via the German procurement portal.
Summary made from the German notice and checked against it; the German original is authoritative.
Key points for a bid
The notice links the tender documents directly. The contract runs for 24 months.
Deadlines and dates
| Published | Thursday, 17 September 2026 |
|---|---|
| Deadline | Wednesday, 5 September 2029, 12:00 |
| Tender validity ends (calculated) | Friday, 5 October 2029 |
Conditions stated in the notice
| Duration | 24 months |
|---|---|
| Framework agreement | no |
| Tender validity | 1 month after the deadline |
| Suitable for SMEs | not stated |
| Security deposit | not required |
| Legal basis | GWB and VgV (German law implementing the EU directives) |
Service by CPV code
- 33600000 Pharmaceutical products
Questions and answers
When is the deadline for offers?
Until Wednesday, 5 September 2029, 1039 days left. The exact time and how to submit are in the original notice, which is authoritative.
Is this tender open to foreign companies?
Yes. Because it is above the EU thresholds, the procedure follows the EU directives, which rule out discrimination by nationality. Suitability can first be shown with the European Single Procurement Document (ESPD).
Which rules apply?
German procurement law implementing the EU directives (GWB and VgV; for works VOB/A EU).
In which language are the documents and the offer?
Expect German. The accepted languages are stated in the notice, and certificates in another language may have to be submitted with a translation.
Sources
Notice: TED, Amtsblatt der Europäischen Union, retrieved 1 November 2026. All information without guarantee; the original notice is authoritative.